Essity AB (ESSITY-B.ST) is a leading global hygiene and health company with a portfolio of strong brands including TENA, Tork, and Libero. The company has been undergoing a significant transformation, focusing on cost efficiencies, premiumization, and sustainability. With a market cap of approximately $18 billion, Essity fits within the lower mid-cap range and offers a defensive yet growing business model.
Investment Thesis
Essity is a consumer compounder benefiting from secular trends in hygiene, health, and sustainability. The company’s restructuring efforts, including the separation of its Vinda business and cost-saving initiatives, are expected to drive margin expansion and earnings growth. With a strong balance sheet and consistent free cash flow generation, Essity is well-positioned to reward shareholders through dividends and potential buybacks.
12-Month Catalysts
- Margin recovery from cost savings and premium product mix, targeting EBITA margin above 15%.
- Organic sales growth driven by innovation in professional hygiene and consumer tissue.
- Potential divestitures or portfolio optimization unlocking value.
Key Risks
- Raw material cost inflation (pulp, energy) could pressure margins.
- Intense competition in the hygiene market may limit pricing power.
Valuation Summary
Essity trades at a forward P/E of ~16x, a discount to peers like Kimberly-Clark (~19x) and Procter & Gamble (~24x). With expected EPS growth of 8-10% annually, the PEG ratio is below 2, suggesting reasonable valuation for a defensive compounder.
Balance Sheet Summary
Essity has a net debt/EBITDA of ~1.5x, investment-grade credit rating, and strong free cash flow conversion (>80%). The balance sheet provides flexibility for M&A or shareholder returns.
Disclaimer: This is not financial advice. Investing involves risk, including loss of principal. Please conduct your own research or consult a financial advisor.